查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534273

全球基因分析儀市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Genetic Analyzer Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 225 Pages | 商品交期: 最快1-2個工作天內

價格

全球基因分析儀市場需求預計將從 2023 年的 117.5 億美元達到近 244.4 億美元的市場規模，2024-2032 年研究期間複合年成長率為 8.48%。

遺傳分析儀是用於遺傳分析的先進儀器，包括 DNA 定序、基因分型和基因表現譜。這些設備使研究人員和臨床醫生能夠在分子層面上檢查遺傳物質，從而深入了解遺傳變異、突變和遺傳狀況。這些分析儀使用微陣列分析、聚合酶鍊式反應和下一代定序 (NGS) 等各種技術來提供準確且全面的遺傳資料。這些資訊對於醫學診斷、個人化醫療和基因研究的應用至關重要。透過識別與疾病和藥物反應相關的遺傳標記，這些分析儀支持標靶療法的開發，並為基因組學和個人化醫療保健的進步做出貢獻。

市場動態

由於遺傳性疾病和慢性病的盛行率不斷上升，以及對個人化醫療的需求不斷成長，遺傳分析儀市場正在迅速擴大。遺傳分析儀為診斷和了解遺傳狀況提供了重要工具，從而實現更精確和個人化的治療計劃。基因分析技術的進步也推動了市場的成長。下一代定序 (NGS) 和基於 CRISPR 的技術等創新提高了遺傳分析的準確性、速度和可擴展性。這些進步使得全面的全基因組研究和識別以前無法檢測到的遺傳變異成為可能，從而推進研究和臨床應用。對基因組研究的日益重視以及將遺傳資料整合到臨床實踐中進一步貢獻了市場機會。政府和研究機構正在基因組學計劃上投入資金，為採用基因分析儀創造了有利的環境。基因組資料庫和生物庫的擴展也支持新型診斷和治療方法的開發。消費者對健康基因檢測（包括血統和生活方式見解）興趣的增加，為市場成長提供了額外的機會。隨著公眾對遺傳資訊價值的認知不斷提高，對可訪問且可靠的遺傳分析解決方案的需求不斷成長。然而，高成本和複雜的監管要求可能會限制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球遺傳分析儀市場的每個細分市場進行了包容性評估。基因分析儀產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

基因分析儀市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

  • 試劑和試劑盒
  • 儀器儀表
  • 軟體

通過測試

  • 預測性基因檢測
  • 營運商測試
  • 產前和新生兒檢測
  • 疾病診斷測試
  • 藥物基因組測試
  • 其他

按申請

  • 癌症
  • 遺傳疾病
  • 心血管疾病
  • 罕見疾病
  • 傳染病
  • 其他

依技術

  • 新一代定序 (NGS)
  • 即時螢光定量PCR系統
  • 其他

按最終用途

  • 醫院
  • 研究與開發實驗室
  • 診斷中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的基因分析儀市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。基因分析儀市場的主要參與者包括 Thermo Fisher Scientific、Abbott Laboratories、PerkinElmer Inc.、BioRad Laboratories、AutoGenomics Inc.、ELITech Group、IntegraGen、Quest Diagnostics Inc.、Hoffmann-La Roche AG、Celera Group、Qiagen、Danaher（造父變星）。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：遺傳分析儀 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力測試分析
    • 市場吸引力分析：依應用分類
    • 按技術分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球基因分析儀市場分析：依產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 試劑和試劑盒
  • 儀器儀表
  • 軟體

第 6 章：全球基因分析儀市場分析：通過測試

  • 測試概述
  • 歷史和預測數據測試分析
  • 預測性基因檢測
  • 營運商測試
  • 產前和新生兒檢測
  • 疾病診斷測試
  • 藥物基因組測試
  • 其他

第 7 章：全球遺傳分析儀市場分析：依應用分類

  • 概述：按應用
  • 歷史與預測資料分析：按應用分類
  • 癌症
  • 遺傳疾病
  • 心血管疾病
  • 罕見疾病
  • 傳染病
  • 其他

第 8 章：全球基因分析儀市場分析：依技術分類

  • 依技術概述
  • 按技術進行歷史和預測數據分析
  • 新一代定序 (NGS)
  • 即時螢光定量PCR系統
  • 其他

第 9 章：全球基因分析儀市場分析：依最終用途

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 醫院
  • 研究與開發實驗室
  • 診斷中心
  • 其他

第 10 章：全球遺傳分析儀市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章：基因分析儀公司的競爭格局

  • 基因分析儀市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Thermo Fisher Scientific
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abbott Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PerkinElmer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BioRad Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • AutoGenomics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • ELITech Group
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • IntegraGen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quest Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Hoffmann-La Roche AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Celera Group
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Qiagen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher (Cepheid)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115348

The global demand for Genetic Analyzer Market is presumed to reach the market size of nearly USD 24.44 Billion by 2032 from USD 11.75 Billion in 2023 with a CAGR of 8.48% under the study period 2024-2032.

Genetic analyzers are advanced instruments for genetic analyses, including DNA sequencing, genotyping, and gene expression profiling. These devices enable researchers and clinicians to examine genetic material at a molecular level, providing insights into genetic variations, mutations, and hereditary conditions. These analyzers use various technologies, such as microarray analysis, polymerase chain reaction, and next-generation sequencing (NGS), to deliver accurate and comprehensive genetic data. This information is crucial for applications in medical diagnostics, personalized medicine, and genetic research. By identifying genetic markers linked to diseases and response to medications, these analyzers support the development of targeted therapies and contribute to advancements in genomics and personalized healthcare.

MARKET DYNAMICS

The genetic analyzer market is expanding rapidly due to the escalating prevalence of genetic disorders and chronic diseases, together with the growing demand for personalized medicine. Genetic analyzers provide essential tools for diagnosing and understanding genetic conditions, enabling more precise and individualized treatment plans. Technological advancements in genetic analysis technologies are also driving market growth. Innovations such as next-generation sequencing (NGS) and CRISPR-based technologies enhance genetic analyses' accuracy, speed, and scalability. These advancements enable comprehensive genome-wide studies and the identification of previously undetectable genetic variants, advancing research and clinical applications. The growing emphasis on genomic research and the integration of genetic data into clinical practice further contribute to market opportunities. Governments & research institutions are spending on genomics initiatives, creating a favorable environment for adopting genetic analyzers. The expansion of genomic databases and biobanks also supports the development of novel diagnostic & therapeutic approaches. The rise in consumer interest in genetic testing for health and wellness, including ancestry and lifestyle insights, presents additional opportunities for market growth. As public awareness of genetic information's value increases, there is a growing demand for accessible and reliable genetic analysis solutions. However, high costs and complex regulatory requirements may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genetic Analyzer. The growth and trends of Genetic Analyzer industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Genetic Analyzer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagents & Kits
  • Instruments
  • Software

By Test

  • Predictive Genetic Testing
  • Carrier Testing
  • Prenatal and Newborn Testing
  • Disease Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

By Application

  • Cancer
  • Genetic Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Infectious Diseases
  • Others

By Technology

  • Next-generation Sequencing (NGS)
  • Real-Time PCR System
  • Others

By End-use

  • Hospitals
  • Research & Development Laboratories
  • Diagnostic Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Genetic Analyzer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genetic Analyzer market include Thermo Fisher Scientific, Abbott Laboratories, PerkinElmer Inc., BioRad Laboratories, AutoGenomics Inc., ELITech Group, IntegraGen, Quest Diagnostics Inc., Hoffmann-La Roche AG, Celera Group, Qiagen, Danaher (Cepheid). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENETIC ANALYZER - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Test
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Reagents & Kits Historic and Forecast Sales By Regions
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY TEST

  • 6.1. Overview By Test
  • 6.2. Historical and Forecast Data Analysis By Test
  • 6.3. Predictive Genetic Testing Historic and Forecast Sales By Regions
  • 6.4. Carrier Testing Historic and Forecast Sales By Regions
  • 6.5. Prenatal and Newborn Testing Historic and Forecast Sales By Regions
  • 6.6. Disease Diagnostic Testing Historic and Forecast Sales By Regions
  • 6.7. Pharmacogenomic Testing Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Cancer Historic and Forecast Sales By Regions
  • 7.4. Genetic Diseases Historic and Forecast Sales By Regions
  • 7.5. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 7.6. Rare Diseases Historic and Forecast Sales By Regions
  • 7.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data Analysis By Technology
  • 8.3. Next-generation Sequencing (NGS) Historic and Forecast Sales By Regions
  • 8.4. Real-Time PCR System Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data Analysis By End-use
  • 9.3. Hospitals Historic and Forecast Sales By Regions
  • 9.4. Research & Development Laboratories Historic and Forecast Sales By Regions
  • 9.5. Diagnostic Centers Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE GENETIC ANALYZER COMPANIES

  • 11.1. Genetic Analyzer Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF GENETIC ANALYZER INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Abbott Laboratories
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. PerkinElmer Inc.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. BioRad Laboratories
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. AutoGenomics Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. ELITech Group
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. IntegraGen
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Quest Diagnostics Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Hoffmann-La Roche AG
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Celera Group
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Qiagen
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Danaher (Cepheid)
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Test (USD MN)
  • Predictive Genetic Testing Market Sales By Geography (USD MN)
  • Carrier Testing Market Sales By Geography (USD MN)
  • Prenatal and Newborn Testing Market Sales By Geography (USD MN)
  • Disease Diagnostic Testing Market Sales By Geography (USD MN)
  • Pharmacogenomic Testing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Genetic Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Next-generation Sequencing (NGS) Market Sales By Geography (USD MN)
  • Real-Time PCR System Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research & Development Laboratories Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Genetic Analyzer Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genetic Analyzer Report
  • Market Research Process
  • Market Research Methodology
  • Global Genetic Analyzer Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Test
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Test (USD MN)
  • Predictive Genetic Testing Market Sales By Geography (USD MN)
  • Carrier Testing Market Sales By Geography (USD MN)
  • Prenatal and Newborn Testing Market Sales By Geography (USD MN)
  • Disease Diagnostic Testing Market Sales By Geography (USD MN)
  • Pharmacogenomic Testing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Genetic Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Next-generation Sequencing (NGS) Market Sales By Geography (USD MN)
  • Real-Time PCR System Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research & Development Laboratories Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.